THEIA™ development, and testing of artificial intelligence‐based primary triage of diabetic retinopathy screening images in New Zealand

AIM: To develop and evaluate an artificial intelligence triage system with high sensitivity for detecting referable diabetic retinopathy and maculopathy, while maintaining high specificity for non‐referable disease, for clinical implementation within the New Zealand national diabetic retinopathy scr...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaghefi, E., Yang, S., Xie, L., Hill, S., Schmiedel, O., Murphy, R., Squirrell, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research: Care Delivery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048953/
https://www.ncbi.nlm.nih.gov/pubmed/32794618
http://dx.doi.org/10.1111/dme.14386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048953/
https://www.ncbi.nlm.nih.gov/pubmed/32794618
http://dx.doi.org/10.1111/dme.14386

Ejemplares similares